evidence table
Beta Glucan Immune Randomized Trial Evidence Table
Structured evidence table for Beta Glucan Immune Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Beta Glucan Immune Randomized Trial | However, clinical evidence linking their intake to site-specific upper respiratory mucosal immune health in humans remains limited. | 2 | Kanno T (2026) | Dietary β-1,3/1,6-Glucan from Baker's Yeast Supports Upper Respiratory Mucosal Immune Health in Healthy Adults: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial. |
| Beta Glucan Immune Randomized Trial | SC-BG intake also attenuated declines in s-IgA levels in the posterior oropharyngeal wall and nasopharynx and increased salivary lysozyme concentrations. | 2 | Kanno T (2026) | Dietary β-1,3/1,6-Glucan from Baker's Yeast Supports Upper Respiratory Mucosal Immune Health in Healthy Adults: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial. |
| Beta Glucan Immune Randomized Trial | Background/Objective : Dietary polysaccharides are increasingly recognized as functional nutritional components that support human health through modulation of immune function. | 2 | Kanno T (2026) | Dietary β-1,3/1,6-Glucan from Baker's Yeast Supports Upper Respiratory Mucosal Immune Health in Healthy Adults: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial. |
| Beta Glucan Immune Randomized Trial | Could β-glucans enhance the immune response to SARS-CoV-2 vaccine by inducing trained immunity and boosting neutralizing antibody production? | 4 | Golim M (2026) | Could β-glucans enhance the immune response to SARS-CoV-2 vaccine by inducing trained immunity and boosting neutralizing antibody production? |
Source documents
- Dietary β-1,3/1,6-Glucan from Baker's Yeast Supports Upper Respiratory Mucosal Immune Health in Healthy Adults: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial.
- Could β-glucans enhance the immune response to SARS-CoV-2 vaccine by inducing trained immunity and boosting neutralizing antibody production?